ripekg:evaluation/RIPEAF6AAC41E3D64BA2C |
prov:used |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAF6AAC41E3D64BA2C |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAF6AAC41E3D64BA2C |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripe:concerns |
ripekg:work/RIPEW741A3C53FD28B4F4Effects of synbiotic food consumption on glycemic status and serum hs-CRP in pregnant women: a randomized controlled clinical trial |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripe:recruitmentEndDateExtractionRationale |
No explicit recruitment end date found. |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripe:recruitmentStartDate |
06-2012 |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripe:recruitmentStartDateExtractionRationale |
Methods: 'This randomized placebo-controlled clinical trial was performed in Kashan, Iran, from June 2012 to February 2013'; using the start date of the trial as the recruitment start date per rule 5. |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripe:studyEndDate |
02-2013 |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
ripe:studyEndDateExtractionRationale |
Methods: 'This randomized placebo-controlled clinical trial was performed in Kashan, Iran, from June 2012 to February 2013'; using the end date of the trial as the study end date per rule 5. |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF6AAC41E3D64BA2C-human-2-2 |
ripekg:study-design-evidence/RIPEAF6AAC41E3D64BA2C |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAF6AAC41E3D64BA2C-inspectai-2-2 |